Barriers to and Facilitators for Accessing HPV Vaccination in Migrant and Refugee Populations: A Systematic Review
- PMID: 38543890
- PMCID: PMC10975665
- DOI: 10.3390/vaccines12030256
Barriers to and Facilitators for Accessing HPV Vaccination in Migrant and Refugee Populations: A Systematic Review
Abstract
Human papillomavirus (HPV) is the most prevalent sexually transmitted virus globally and a primary cause of cervical cancer, which ranks fourth among tumors in both incidence and mortality. Despite the availability of effective vaccines worldwide, HPV vaccination rates vary, especially among migrant and refugee populations. Indeed, migrant status may act as a determinant against accessing vaccinations, among many other factors. The objective of this paper is to evaluate barriers to and facilitators for accessing HPV vaccination in migrant and refugee populations. A systematic review of the existing peer-reviewed academic literature was conducted according to the PRISMA 2020 guidelines in which we examined thirty-four studies to evaluate HPV vaccination rates in these populations and identify factors acting as barriers or facilitators. Key determinants include socio-economic status and health literacy. Communication barriers, including language and cultural factors, also impact access to information and trust in the health workforce. Understanding and considering these factors is crucial for developing proper and inclusive vaccination strategies to ensure that no population is overlooked.
Keywords: HPV; migrants; prevention; public health; refugees; social determinants; vaccination; vaccination strategies; vaccine hesitancy.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- European Centre for Disease Prevention and Control . Guidance on HPV Vaccination in EU Countries: Focus on Boys, People Liv-ing with HIV and 9 Valent HPV Vaccine Introduction. Publications Office; Luxembourg: 2020. [(accessed on 26 December 2023)]. Available online: https://data.europa.eu/doi/10.2900/71487. - DOI
-
- Wardak S. Human Papillomavirus (HPV) and cervical cancer. Med. Dosw. Mikrobiol. 2016;68:73–84. - PubMed
-
- Mix J.M., Van Dyne E.A., Saraiya M., Hallowell B.D., Thomas C.C. Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15–29 Years in the United States, 1999–2017: An Ecologic Study. Cancer Epidemiol. Biomark. Prev. 2021;30:30–37. doi: 10.1158/1055-9965.EPI-20-0846. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
